Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | PARP1 | P09874 | 1/20 | 0.53 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17174189 | 0.98 | MEN1 (0.56) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL647692 | 0.98 | MEN1 (0.56) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL29645262 | 0.98 | MEN1 (0.56) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL29444828 | 0.98 | MEN1 (0.56) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL10032415 | 0.96 | MEN1 (0.54) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL31326563 | 0.96 | MEN1 (0.54) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL10032340 | 0.96 | MEN1 (0.54) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL21103888 | 0.94 | MEN1 (0.52) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL21103662 | 0.92 | MEN1 (0.50) | MEN1KMT2ARAB9APARP1ASIC3 | |
| SCHEMBL21103770 | 0.92 | MEN1 (0.50) | MEN1KMT2ARAB9APARP1ASIC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250107432-A1 | DIVALENT EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME | BEEOLED GMBH (DE) | 2025-03-27 | — | — | US | disclosed |
| CN-119431417-A | Divalent europium-organic coordination compound and preparation method thereof | 蜜蜂OLED股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250107432-A1 | DIVALENT EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME | ORC3, OR10J3, OSTC | MEN1 325/4885KMT2A 1920/4885RAB9A 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.